![Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Berman_Table2.gif)
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology
![KLISYRI (tirbanibulin) ointment | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA KLISYRI (tirbanibulin) ointment | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA](https://www.medvitaz.com/wp-content/uploads/2021/07/klisyri-500x500.jpg)
KLISYRI (tirbanibulin) ointment | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA
Translated article] Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratos
![Almirall U.S. Launches Klisyri® (tirbanibulin), a New, Innovative Topical Treatment for Actinic Keratosis | Markets Insider Almirall U.S. Launches Klisyri® (tirbanibulin), a New, Innovative Topical Treatment for Actinic Keratosis | Markets Insider](https://mma.prnewswire.com/media/1440307/Klisyri_OpenBoxImage.jpg)
Almirall U.S. Launches Klisyri® (tirbanibulin), a New, Innovative Topical Treatment for Actinic Keratosis | Markets Insider
![Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis](https://mma.prnewswire.com/media/1385697/klisyri.jpg?p=facebook)
Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis
![Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Berman_Figure4.jpg)
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Berman_Table1.gif)
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology
![These highlights do not include all the information needed to use KLISYRI safely and effectively. See full prescribing information for KLISYRI. KLISYRI (tirbanibulin) ointment, for topical use Initial U.S. Approval: 2020 These highlights do not include all the information needed to use KLISYRI safely and effectively. See full prescribing information for KLISYRI. KLISYRI (tirbanibulin) ointment, for topical use Initial U.S. Approval: 2020](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=klisyri-03.jpg&id=620179)
These highlights do not include all the information needed to use KLISYRI safely and effectively. See full prescribing information for KLISYRI. KLISYRI (tirbanibulin) ointment, for topical use Initial U.S. Approval: 2020
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results - JDDonline - Journal of Drugs in Dermatology
![The Medical Letter on Twitter: "Tirbanibulin 1% Ointment (Klisyri) for Actinic Keratosis https://t.co/lkMA2Sbq9h #ActinicKeratosis https://t.co/GyRi3HNEp9" / Twitter The Medical Letter on Twitter: "Tirbanibulin 1% Ointment (Klisyri) for Actinic Keratosis https://t.co/lkMA2Sbq9h #ActinicKeratosis https://t.co/GyRi3HNEp9" / Twitter](https://pbs.twimg.com/media/E0CAuW7XEAAWS3i.png)